President Biden hailed Eli Lilly & Co. on Wednesday for capping out-of-pocket costs for insulin at $35, a move that aligns with a key priority for the administration.
Please follow and like us:
President Biden hailed Eli Lilly & Co. on Wednesday for capping out-of-pocket costs for insulin at $35, a move that aligns with a key priority for the administration.